India's merchandise trade deficit is expected to have widened to USD 28.0 billion in September 2025, up from USD 26.5 billion in August, according to a report by Union Bank of India.
The United States has announced an additional 100% tariff on Chinese goods, effective November 1, 2025, which will raise the overall tariff rate on Chinese imports to approximately 130%.
India is set to become the next major force in the petrochemicals industry, a move that could intensify supply imbalances already troubling Asia, according to a press release citing recent reports by S&P Global Ratings.
Afghanistan's Ministry of Industry and Commerce said trade with Pakistan fell slightly to USD 1.108 billion in the first half of 2025, down from USD 1.117 billion last year. Tolo News reported officials and analysts urged separating politics from trade to boost ties despite border closures a
The Indian plastics pipes industry weathered multiple headwinds in FY25, grappling with subdued infrastructure spending, liquidity challenges, and volatile PVC prices, according to a recent JM Financial report.
An uptick in non-oil non-gold imports is likely in the coming months as domestic demand expands, at a time when exports could weaken due to mounting tariff pressures.
India currently imports the majority of its critical minerals, often from a few dominant players, which raises concerns about geopolitical risks and supply chain bottlenecks.
The Ministry of External Affairs stated on Friday that India is closely monitoring the impact of US President Donald Trump's announcement to impose tariffs of up to 100% on imports of branded and patented pharmaceutical drugs, effective from October 1, 2025.
Nitin Gadkari, Minister of Road Transport and Highways, Government of India, today announced the launch of India's first hydrogen highways during Day 2 of the inaugural World Hydrogen India, organized by S&P Global Commodity Insights.
European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI).
India's pharmaceutical exports are not expected to face a major impact following the recent announcement of a 100 per cent tariff on branded and patented pharmaceutical products by the US, said Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance (IPA).
Chairperson of the topmost Pharmaceutical company, Pharmexcil, which earns 40 - 50 per cent of its total revenues from the American market also said, "Generic drugs are not impacted".